MITRA — Mithra Pharmaceuticals SA Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Brief: Mithra Receives Additional EUR 2.5 Million To Advance Monetization
Brief: Mithra Secures Court Protection Measures To Advance Monetization Process
Brief: Mithra Pharmaceuticals Achieves LPR In Estetrol Skin Study
Brief: Mithra Applies To Liege Company Court For A "Transfer Under Judicial Supervision" For Mithra CDMO
Mithra slips on low Estelle sales, slow monetisation
Brief: Mithra Pharmaceuticals FY EBITDA EUR -52.771 Million
Brief: Mithra Says Delay In Donesta US NDA Filing Negatively Impacted Process To Consummate US Licensing Agreement, & Negatively Impacting Expected Revenues.
Brief: Mithra Pharmaceuticals End-Year Cash Position At 9.0 Mln Euros
Brief: Mithra Pharmaceuticals Initiates Monetization Process
Brief: Mithra Terminates Management Agreement With CEO David Horn Solomon
Brief: Mithra Says Sells Shares In Mayne Pharma
Brief: Mithra Pharmaceuticals Sells Shares In Mayne Pharma
Brief: Mithra Has Enough Cash Until Early March
Brief: Mithra Pharmaceuticals SA - Transparency Notification From Goldman Sachs Group Inc.
Brief: Mithra And Rafa Laboratories Sign Binding Head Of Terms To Commercialize Donesta® In Israel
Brief: Mithra Pharmaceuticals Completes Pediatric Study Of Estelle In Adolescent Patients
Brief: Mithra Pharmaceuticals And Gedeon Richter Sign Binding Head Of Terms To Commercialize Estelle® And Donesta® In China
Brief: Mithra Gets Guidance From FDA For Donesta® NDA Marketing Authorization Filing In US
Brief: Mithra's Nextstellis® Granted Additional Patent In United States